In 2020, we initiated the COVID-19 vaccine bioreactor project, dedicated to providing crucial support in the global fight against the COVID-19 pandemic. In order to ensure the effectiveness and safety of the vaccine, we optimized bioreactor technology to enhance production efficiency and meet global market demands. We strictly adhere to international quality standards and implement full-process quality control in the production of the vaccine to ensure its safety and effectiveness. We actively participate in international cooperation, engaging in collaborative research and exchange experiences in vaccine development and production with other countries to collectively address the global pandemic challenge.

We established contact with a Chinese animal vaccine company to explore the possibility of collaboration. After initial discussions with the client, we gained a comprehensive understanding of their needs and expectations for foot-and-mouth disease (FMD) vaccine production equipment. Based on the client's requirements, we developed a complete set of FMD vaccine production equipment solutions and held detailed discussions with the client for confirmation. Following thorough communication and negotiation, we officially confirmed the collaboration project and commenced production. Subsequently, we manufactured high-quality core equipment for the FMD vaccine tailored to the client's needs.

Throughout the production process, we strictly adhered to Good Manufacturing Practice (GMP) standards, implementing full-process quality control and testing to ensure the safety and effectiveness of the equipment. Following stringent production and quality inspection processes, we delivered the FMD vaccine production equipment on schedule, earning high praise and recognition from the client. We are committed to providing excellent after-sales service to ensure the normal operation and effective use of the equipment, contributing to the safeguarding of animal health.